The global stoma/ostomy care market holds a valuation of USD 3.8 Billion by the end of the year 2022. Throughout the forecast period of 2023 to 2033, the market is likely to display growth at a CAGR of 4.9%, and is expected to hold a market value of around USD 6.5 Billion in 2033.
Market Outlook
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 3.8 Billion |
| Market Value 2023 | USD 4.0 Billion |
| Market Value 2033 | USD 6.5 Billion |
| CAGR 2023 to 2033 | 4.9% |
| Market Share of Top 5 Countries | 51.7% |
| Key Market Players | Coloplast Corp, BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc., 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc., Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG, Salts Healthcare Ltd., Securi–T USA, Welland Medical Limited and Flexicare Group Limited |
An ostomy device is a piece of artificial gastrointestinal medical device that makes a stoma by collecting waste from a biological system that has been surgically diverted (the colon, ileum, or bladder). An ostomy may be required due to congenital disability, bladder cancer, inflammatory bowel disease, diverticulitis, obesity, and other medical issues. Colostomy, urostomy, and ileostomy are the three main categories.
According to the Centers for Disease Control and Prevention (CDC), IBD (Inflammatory Bowel Disease), also known as Crohn's disease or ulcerative colitis, affects over 3 million (1.3%) individuals in the United States every year. The global market is expected to grow as inflammatory bowel disease becomes more prevalent globally.
The stoma or ostomy care business is expanding, due to advancements in ostomy devices, contributions by manufacturing companies to new technologies and growing patient education campaigns about the use of ostomy devices are the factors propelling the market ahead to grow further.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The stoma/ostomy care market expanded at a CAGR of 5.0% for 2017 to 2022 period.
The global market for stoma/ostomy care contributes around 37.8% to the global gastrointestinal devices market, valued at about USD 10.05 Billion in 2022.
Increasing prevalence of Inflammatory bowel disease (IBD), colorectal cancer, public awareness of ostomy/stoma care, the availability of treatment options, as well as the established reimbursement policies funded by private and governmental organisations, are the main factors driving the stoma/ostomy care industry.
The market is also being driven by technological developments in the area of ostomy care products like the development of effective and well-designed pouching facility and related accessories that serve to enhance the quality of life for ostomy patients.
For instance, Trio Healthcare has launched Trio Siltac in 2016, an ostomy seal made of silicone. This item shields the skin surrounding the stoma and aids in preventing leakage. Over the forecast period, these developments are anticipated to accelerate market expansion.
The industry is expanding as a result of an increase in campaigns to educate people about ostomies. The United Ostomy Association of America Inc. (UOAA) stated that in October 2021, the UOAA was striving to raise the bar for care in all healthcare settings and to enhance the standard of ostomy healthcare in the USA
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 3.43% |
| Jul to Dec (H2), 2021 (A) | 4.26% |
| Jan to Jun (H1),2022 Projected (P) | 3.39% |
| Jan to Jun (H1),2022 Outlook (O) | 3.69% |
| Jul to Dec (H2), 2022 Outlook (O) | 4.59% |
| Jul to Dec (H2), 2022 Projected (P) | 4.32% |
| Jan to Jun (H1), 2023 Projected (P) | 3.51% |
| BPS Change : H1,2022 (O) – H1,2022 (P) | 30↑ |
| BPS Change : H1,2022 (O) – H1,2021 (A) | 26↑ |
| BPS Change: H2, 2022 (O) – H2, 2022 (P) | 27↑ |
| BPS Change: H2, 2022 (O) – H2, 2022 (A) | 34↑ |
Principal Consultant
The market for ostomy care products is highly driven by the increasing prevalence of patient pool suffering from cancers including colon and rectum cancer. This is increasing demand for various ostomy care products especially for the bedridden patients.
Companies have been manufacturing products with human-centric design - comfortable, light, leak-free, and gently fits and moves with the patient's body as they bend. Hence, preferred by both patients and healthcare professionals.
ConvaTec Inc.'s Esteem+ Flex Convex product, for example, has a hydrocolloid skin barrier, stays firm with minimal leakage, and resists snagging on clothing.
The availability of numerous e-commerce sites selling surgical procedure-related products may increase sales of stoma care products. Some popular e-commerce sites such as Express Medical Supply Inc.
and Amazon-Stoma bags that provide discounts, warranties, and prompt customer service on a variety of stoma care accessories. All of these factors are expected to provide a much-needed boost to the stoma/ostomy care sector.
Poor economic conditions in developing countries, a lack of reimbursement for ostomy care bags, a postoperative surgical complication, elevated risks involved with ostomy surgeries, anaesthesia reaction, bleeding, blood clots, septicaemia, wound infection, and unpleasant psychological and emotional effects of the ostomy or stoma surgery are all expected to hinder the stoma or ostomy care market.
The primary issue limiting the stoma care and accessories industry is ineffective and insufficient ostomy care accessory payment rules. Patients frequently obtain unnecessary National Health Service goods, resulting in billing or incorrect charging. The estimated incorrect billing amount for ostomy products in the USA for the year 2020 is USD 93.4 million, according to the Medicare Learning Network. As a result of the troubling reimbursement procedures, concerns about inappropriate stoma care supply invoicing, are expected to impede the stoma or ostomy care market.
Although stomas are a relatively common and safe surgery, there are some risks. For example, skin irritation from ostomy appliance adhesive, risk of dehydration from waste exiting the stoma, leakage due to improper fitting, bowel obstruction due to improper food chewing or digestion, parastomal hernia, or necrosis. Most stoma complications are minor, but necrosis and dehydration can become medical emergencies.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The USA |
|---|---|
| Market Share (2023) | 28.7% |
| Market Share (2033) | 26.4% |
| BPS Analysis | -227 |
| Country | Indonesia |
|---|---|
| Market Share (2023) | 7.2% |
| Market Share (2033) | 7.2% |
| BPS Analysis | 6 |
| Country | Russia |
|---|---|
| Market Share (2023) | 5.5% |
| Market Share (2033) | 6.8% |
| BPS Analysis | 127 |
| Country | Germany |
|---|---|
| Market Share (2023) | 5.3% |
| Market Share (2033) | 4.7% |
| BPS Analysis | -60 |
| Country | Spain |
|---|---|
| Market Share (2023) | 5.0% |
| Market Share (2033) | 5.2% |
| BPS Analysis | 18 |
The USA market will hold the market share of around 28.7% in 2023 global market.
The USA currently is the largest shareholder in the global market. This may be attributed to a rising prevalence of IBD and increased awareness among population regarding ostomy care or stoma procedures. In addition, the ageing population anticipates an increase in the prevalence of IBD, colon, and bladder malignancies in the future.
According to the American Cancer Society, about 106,180 and 44,850 new cases of colorectal cancer and rectal cancer were reported in the USA for the year 2021.
According to Crohn’s and Colitis Foundation of America, around one in 500 Americans requires an ostomy drainage bag. 30% of those with U.C. will ultimately require ostomy bags, whether they are needed temporarily or permanently.
The Germany is set to hold around 5.3% of global market share in stoma/ostomy care in 2023.
According to GLOBOCAN statistics, colorectal cancer (CRC) is the fourth most common type of cancer among the German population, at about 57,528 new cases reported in Germany in 2021. Germany dominates market growth due to the high prevalence of Inflammatory Bowel Diseases (IBD), such as ulcerative colitis and Crohn's disease, which results in an increase in ostomy surgery cases.
A larger patient pool, as well as a better reimbursement structure and private insurance policies, all contribute to the growth in German market. Other factors driving this region’s growth includes an ageing population, an increase in cases of intestinal disorders, and increased investment in research and development, improved diagnostic technologies for chronic diseases, and the availability of products at an affordable price.
The Indian market is projected to expand at a CAGR of 3.8% during the forecast period.
Colorectal cancer is becoming more common in India. The risk increases with age, most cases being diagnosed in adults aged 65 to 74 years. As per Globocan 2018 data, there were 1,157,294 cancer cases and 784821 cancer deaths reported in 2018. Colorectal cancer occurred at a rate of 4.9% in India in 2018, with a death rate of 5.5%. In 2018, the incidence of stomach cancer was 5.0%, with a death rate of 6.6%.
Several nursing centres in this region offer a variety of initiatives to raise awareness among ostomy patients, including motivational programmes and instructional lectures. For example, India is a member of the Asia and South Pacific Ostomy Association (ASPOA) and helps to organise World Ostomy Day in India every year to improve ostomy rehabilitation by bringing their goals and needs to the general public and Indian community's attention.
Additionally, a number of market players are trying to improve distribution networks in this region to take advantage of their growth prospects.
Ostomy Bags is expected to hold a significant revenue share of 84.3% in the global market by 2023, owing to an increasing number of patients suffering from target diseases such as colorectal cancer.
Crohn's disease, ulcerative colitis, and IBD symptoms can be extremely difficult at times, causing physical challenges as well as emotional distress. Considering patient’s ease, companies have developed ostomy bags which are ready to throw away once they are about three-quarters full, waterproof, leak-proof, odour-free and with lightly scented, closed bags are easy to change quickly at night or while travelling, and come in three sizes, small, midi (medium)
The colostomy segment is expected to hold significant market share of 88.8% within the global market in 2023 owing to the increased prevalence of IBD, bowel cancer, and colon cancer in both developed and developing countries, as well as the favourable reimbursement environment in developed countries.
Colostomy also aids in medical conditions where the colon or anus must be temporarily stopped in order to heal the gastrointestinal tract. After the patient has fully recovered from the first surgery, another surgery will be performed to reattach the ends of the large intestine. A colostomy procedure could be a long-term solution to an irreversible condition.
Cancer segment is anticipated to hold a market share around 58.0% in 2023 global market.
According to a 2019 article published in Prezeglad Gatroenterologiczny Journal on the epidemiology of gastric cancer, based on GLOBOCAN 2018 data, stomach cancer is the fifth most common cancer, contributing for 5.7% more new cases, and the third deadliest cancer, accounting for an estimated 783,000 deaths in 2018.
The home care settings segment is expected to hold a market share around 67.2% in 2023 globally.
Home Settings include large and small home health care, adult day-care centers and assisted living facilities. This segment's growth in the global market is being driven by a growing patient pool and reimbursement policies in most industrialised countries.
The home care setting is more popular because patients can receive continuous care from home by reading self-management manuals, occasional visits by nurse, using telemedicine, communicating via phone, and accepting follow-ups for doctors.
The leading players active within this space are focussing on developing products with advanced technology to suit wide variety of population. Additionally, they are highly active in raising funds to expand their customer pool in new regions.
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the stoma/ostomy care market, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | USD Million for Value, and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United kingdom, Germany, Italy, France, Spain, Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC countries, Türkiye, South Africa and North Africa. |
| Key Market Segments Covered | Product, Surgery, Application, End User, and Region |
| Key Companies Profiled |
BAE Systems Plc; ConvaTec Inc.; Hollister Inc.; EuroMed, Inc; 3M Company; Smith & Nephew plc; FNC Medical; Nu–Hope Laboratories, Inc.; Marlen Manufacturing & Development Co.; Torbot Group, Inc; Cymed Micro Skin; Alcare Co., Ltd.; B. Braun Melsungen AG.; Salts Healthcare Ltd; Securi–T USA.; Welland Medical Limited; Flexicare Group Limited |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global stoma/ostomy care sector is worth USD 3.8 Billion in 2022 and is set to expand 1.5X over the next ten years.
The global market is expected to reach a valuation of USD 4.0 Billion by the end of 2023.
Stoma/ostomy care market is expected to reach USD 6.5 Billion by the end of 2033, with sales revenue expected to register 4.9% CAGR over the forecast duration.
The global market expanded at a CAGR of about 5.0% over the last 5 years between 2017 and 2022.
The global market is projected to expand at a CAGR of around 4.9% between 2023 and 2033.
The USA, China, Germany, Russia, and Indonesia are expected to drive demand for stoma/ostomy care products.
Coloplast Corp, BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc., 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc., Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG, Salts Healthcare Ltd., Securi–T USA, Welland Medical Limited and Flexicare Group Limited are some of the key players active in this space.
Ostomy Bags is expected to hold a significant revenue share of 84.3% in the global market by 2023.
The USA market will hold the market share of around 28.7% in 2023 global market.
The market is valued at USD 4 billion in 2023.
The market captured a CAGR of 5% from 2017 to 2022.
The market is predicted to reach USD 6.5 billion in 2033.
The market is projected to expand at a 4.9% CAGR through 2033.
ConvaTec Inc., Hollister Inc., and, EuroMed, Inc. are the leading market players.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 6. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8.1. Manufacturer Level Pricing 8.2. Distributor Level Pricing 8. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Surgery Type 10.1. Colostomy 10.2. Ileostomy 10.3. Urostomy 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 10.1. Ostomy Bags/Pouches 10.2. Ostomy Accessories 10.2.1. Belts & Tapes 10.2.2. Skin Protection & Skin Barrier 10.2.3. Irrigation Sets 10.2.4. Convex Inserts 10.2.5. Stoma Caps 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 12.1. Cancer 12.2. Inflammatory Bowel Disease 12.3. Bowel Obstruction 12.4. Fecal Incontinence 12.5. Trauma & Infection 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 13.1. Hospital and Specialty Clinics 13.2. Home Care Settings 13.3. Ambulatory Surgical Centers 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 14.1. North America 14.2. Latin America 14.3. Europe 14.4. East Asia 14.5. South Asia 14.6. Oceania 14.7. Middle East and Africa 14 North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033 21. Market Structure Analysis 22. Competition Analysis 22.1. Coloplast Corp 22.2. BAE Systems Plc 22.3. ConvaTec Inc. 22.4. Hollister Inc. 22.5. EuroMed, Inc 22.6. 3M Company 22.7. Smith & Nephew plc 22.8. FNC Medical 22.9. Nu-Hope Laboratories, Inc. 22.10. Marlen Manufacturing & Development Co. 22.11. Torbot Group, Inc 22.12. Cymed Micro Skin 22.13. Alcare Co., Ltd. 22.14. B. Braun Melsungen AG 22.15. Salts Healthcare Ltd 22.16. Securi-T USA. 22.17. Welland Medical Limited 22.18. Flexicare Group Limited 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Stoma/Ostomy Care Market
